Aim To evaluate efficacy and safety of iris-supported phakic lenses (Verisyse) for treating moderately high myopia. Methods This prospective clinical study included 40 eyes from 29 patients, who underwent implantation of Verisyse for correction of myopia from -6.00 to -14.50 diopters (D) in the Eye Clinic ‘’Svjetlost’’, Sarajevo, from January 2011 to January 2014. Uncorrected distance visual acuity (UDVA), manifest residual spherical equivalent (MRSE), postoperative astigmatism, intraocular pressure (IOP), endothelial cell (EC) density were evaluated at one, three, six and twelve months. Corrected visual acuity (CDVA), index of safety and efficacy were evaluated after 12 months. Results Out of 29 patients 15 were males and 14 females, with mean age of 27.9 ± 5.0. After 12 months 77.5% eyes had UDVA ≥ 0.5 and 32.5% had UDVA ≥ 0.8. Mean MRSE was 0.55D ±0.57D and mean postoperative astigmatism -0.86D ± 0.47D. Efficacy index was 1.09 ± 0.19 and safety index 1.18 ± 0.21. One eye (2.5%) lost two Snellen lines and three eyes (7.5%) one line, 11 eyes (27.5%) gained one line, and five eyes (15.5%) gained two lines. EC loss after 12 months was 7.59 ± 3.05%. There was no significant change of IOP after one year follow up. Conclusion Implantation of iris-supported phakic lenses (Verisyse) for treating moderately high myopia is an efficient and safe procedure.
Moshirfarm I, Ostler E, Muthappan W. Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens. ClinOphthalmol. 2014;711–6.
2.
Gonnermann J, Klamann M, Maier A. Visual outcome and complications after posterior iris-claw aphakic intraocular lens implantation. J Cataract Refract Surg. 2012;2139–43.
3.
Patel S, Chu D, Ayres B, Hersh P. Corneal edema and penetrating keratoplasty after anterior chamber phakic intraocular lens implantation. J Cataract Refract Surg. 2005;2212–5.
4.
Stulting R, John M, Maloney R, Assil K, Arrowsmith P, Thompson V. Three-year results of Artisan/Verisysephakic intraocular lens implantation. Ophthalmology. 2008;464–72.
5.
Menezo J, Peris-Martı´nez C, Cisneros-Lanuza A, Costa M, R. Rate of cataract formation in 343 highly myopic eyes after implantation of three types of phakic intraocular lenses. J Refract Surg. 2004;317–24.
6.
Ruiz-Moreno J, Montero J, De L, Vega C, Alio´ J, Zapater P. Retinal detachment in myopic eyes after phakic intraocular lens implantation. J Refract Surg. 2006;247–52.
7.
Keenan T, Jones M, Rushton S, Carleyfm. Trends in the indications for corneal graft surgery in the United Kingdom: 1999 through. Arch Ophthalmol. 2009;621–8.
8.
Lackner B, Pieh S, Schmidinger G, Hanselmayer G, Dejaco-Ruh-Swurm I, Funovics M, et al. Outcome after treatment of ametropia with implantable contact lenses. Ophthalmology. 2003;2153–61.
9.
Singer J. Frown incision for minimizing induced astigmatism after small incision cataract surgery with rigid optic intraocular lens implantation. J Cataract Refract Surg. 1991;677–88.
10.
Maloneyrk, Nguyen L, John M. Artisan phakic intraocular lens for myopia; short-term results of prospective, multicenter study; the Artisan Lens Study Group. Ophthalmology. 2002;1631–41.
11.
Coullet J, Guell J, Fourine P, Grandjean H, Gayatan J, Arne J, et al. Iris-supported phakic lenses (rigid svfoldable version) for treating moderately high myopia: randomized paired eye comparison. AM J of Ophtalmol. 2006;909–16.
12.
Budo C, Hessloehl J, Izak M. Multicenter study of the Artisan phakic intraocular lens. J Cataract Refract Surg. 2000;1163–71.
13.
Gierek-Ciaciura S, Gierek-Lapinska A, Mrukwa-Kominek E. Correction of high myopia with different phacik anterior chamber intraocular lenses: ICARE angle-supported lens and Verisyse iris claw lens. GreafesAtrchClinExpOphthalmol. 2007;1–7.
14.
Senthil S, Reddy K, Ravisankar, Srilakhmi. A retrospective analysis of the first Indian Experience on Artisan phakic intraocular lens. Indian J Ophtalmol. 2006;251–5.
15.
Malecase F, Hulin H, Bierer P, Fourine P, Grandjean H, Thalamas C, et al. A randomized paired eye comparison of two techniques for treating moderately high myopia; LASIK and Artisan phakic lens. Ophthalmology. 2002;1622–30.
16.
Basic and Clinical Science Course 2012-2013. Section 13: Refractive Surgery. American Academy of Ophthalmology. 2012;125–49.
17.
Pop M, Payette Y. Initial results of endothelial cell counts after Artisan lens for phakic eyes: an evaluation of the United States Food and Drug Administratio-nOphtec Study. Ophthalmology. 2004;309–17.
18.
Sanders D, John. Comparison of implantable contact lens and laser assisted in situ keratomileusis for moderate to high myopia. Cornea. 2003;324–31.
19.
Dong Z, Wang N, Hao L, Wang H, Zhang H. Clinical analysis of long term safety after implantation of iris-fixed phakic intraocular lens Verisyse. Zhonghua Yan KeZaZhi. 2012;707–12.
20.
Martinez-Castillo V, Boixadera A, Verdugo A, Elies D, Coret A, Garcia-Arumi J. Rhegmatogenous retinal detachment in phakic eyes after posterior chamber phakic intraocular lens implantation for severe myopia. Ophthalmology. 2005;580–5.
Poliklinika ’ ’, Svjetlost ’, Sarajevo, Bosna I Hercegovina, Specijalna Bolnicazaoftalmologiju’’svjetlost ’, Zagreb, et al. Svjetlost" Sarajevo, od januara 2011. do januara 2014. godine. Nekorigovana vidna oštrina za daljinu (UDVA), manifestni rezidualni sferni ekvivalent (MRSE), postoperativni astigmatizam, intraokularni pritisak (IOP) te gustoća endotelnih ćelija (EC) evaluirani su na jedan, tri, šest i 12 mjeseci. Korigovana vidna oštrina (CDVA), indeks sigurnosti i efikasnosti evaluirani su nakon 12 mjeseci. Rezultati Od 29 pacijenata 15 su bili muškarci, a 14 žene. sa srednjom vrijednosti godina. :47.
23.
D. Jedno oko (2,5%) je izgubilo dvije Snellenove linije, a tri oka (7,5%) jednu liniju; 11 očiju (27,5%) je dobilo jednu liniju, a pet očiju (15,5%) dobilo je dvije linije. Gubitak endotelnih ćelija, nakon 12 mjeseci, iznosio je 7,59 ± 3,05%. Nije bilo statistički značajne promjene u visini očnog pritiska u toku perioda praćenja. Zaključak Implantacija iris-fiksirajućih fakičnih leća (Verisyse) je efikasna i sigurna metoda za tretman srednje visoke miopije.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
